Lynn Seely, President and CEO at Lyell Immunopharma, Inc. (LYEL), sold 7,455 shares at $23.39 ($174K) on 2026-02-11, disclosed to the SEC on 2026-02-12.
Open-market sale of $174k LYEL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LYEL | SELL | 2026-06-15 | $7K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $10K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $7K | — | Filing → |